Artificial Intelligence Race in 2025: The Battle Intensifies

The competition in Artificial Intelligence heats up as breakthroughs in 2024 set the stage for a tighter race in 2025.

The artificial intelligence race is intensifying, with a significant rise in high-performing Chinese AI models challenging the United States´ dominance. A recent report on the industry highlights that the gap in performance between top AI models is shrinking, making the competition fiercer. The Chatbot Arena Leaderboard indicates a narrowing gap in scores from 12% in 2024 to just 5% in 2025 among the top ten models.

The Artificial Intelligence Index Report 2025, released by Stanford University´s Institute for Human Centered AI, reveals that while AI models are growing in complexity, smaller models are also proving to be remarkably competitive. Thanks to advanced algorithms, these models now achieve the high performance once exclusive to much larger models, marking 2024 as a breakthrough year for smaller AI models.

The report further details the dominance of the industry in AI model development, which contrasts with earlier years when academia led the field. The United States remains the leading producer of notable models, yet China´s growth is notable, matching U.S. performance in certain benchmarks by the end of 2024. Open-weight models like DeepSeek and Facebook´s LLaMa are gaining traction, closing the performance gap with closed systems to just 1.7%.

73

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.